Symani Restore study for moyamoya disease surgery
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests if the Symani surgical system helps surgeons perform a delicate brain blood-vessel bypass in people with moyamoya disease. It may offer a precise, minimally invasive option for those needing neurosurgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You have moyamoya disease with mild to moderate symptoms that requires brain surgery.
- You are willing to have the surgery and anesthesia.
- You agree to participate in the study and sign a consent form.
- You do not have a bleeding or clotting disorder, now or in the past.
- You are medically stable enough for prolonged anesthesia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study at Vanderbilt tests whether certain biomarkers (signs in your blood or brain scans) can help tailor care for people with Moyamoya, a condition where blood flow to the brain is reduced. Participants will have brain scans and complete study procedures before and after surgery to improve blood flow.
This study is building a tool to predict how people with moyamoya disease will do after brain surgery to improve blood flow. If you are an adult with moyamoya and are scheduled for this surgery, you may be able to help.
This study tests if statins (cholesterol-lowering drugs) can help people with Moyamoya disease. The trial will follow patients who receive either surgery or standard care to see if adding a statin improves outcomes.
This trial follows people with moyamoya disease who are treated with medication only, and it also looks at first-degree relatives. The goal is to understand long-term outcomes and whether careful conservative care is beneficial over time.
This study looks at why some people with moyamoya disease have trouble with thinking and memory. It may help find better ways to understand and treat these problems.
This trial tests whether a daily aspirin regimen combined with a blood-pressure cuff treatment on the arm can slow the progression of mild moyamoya disease. It aims to reduce the risk of strokes and bleeding events.
Hear when a new Moyamoya Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.